Horizant and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Horizant (gabapentin enacarbil).
Gabapentin Food/Lifestyle
Moderate Food Interaction
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
References (4)
- Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
- Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
- (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
- (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc
Switch to consumer interaction data
Horizant drug interactions
There are 271 drug interactions with Horizant (gabapentin enacarbil).
Horizant disease interactions
There are 4 disease interactions with Horizant (gabapentin enacarbil) which include:
More about Horizant (gabapentin enacarbil)
- Horizant consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: gamma-aminobutyric acid analogs
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Neupro
Neupro Skin Patches (rotigotine) are used to treat early signs and symptoms of Parkinson's disease ...
Inbrija
Inbrija is an inhaled medicine used to treat the symptoms of Parkinson's disease. Includes side ...
Requip XL
Requip XL is used for parkinson's disease, periodic limb movement disorder
Rotigotine
Rotigotine is used for parkinson's disease, restless legs syndrome
Levodopa
Levodopa is used for parkinson's disease, parkinsonism, periodic limb movement disorder, restless ...
Pramipexole
Pramipexole is used for parkinson's disease, periodic limb movement disorder, restless legs ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.